# Comparing Ginkgo Biloba Pills and Placebo in the Treatment of Coronary Heart Disease With Impaired Glucose Regulation

> **NCT03483779** · PHASE4 · UNKNOWN · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 12 (estimated)

## Conditions studied

- Randomized Controlled Trial
- Ginkgo Biloba Extract

## Interventions

- **DRUG:** Ginkgo biloba pills
- **DRUG:** placebo pills

## Key facts

- **NCT ID:** NCT03483779
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-25
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483779, "Comparing Ginkgo Biloba Pills and Placebo in the Treatment of Coronary Heart Disease With Impaired Glucose Regulation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03483779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*